Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dyck

Showing results (471-480 of 549) with videos related to

Pageof 55
Sort By:
The American Journal of Physiology|September 2, 1998
Palmitate transport and fatty acid transporters in red and white musclesA Bonen, J J Luiken, S Liu, et al.
Journal of the Neurological Sciences|September 17, 2018
Kind and distribution of cutaneous sensation loss in hereditary transthyretin amyloidosis with polyneuropathyMarcus V Pinto, P James B Dyck, Linde E Gove, et al.
Neurology|February 1, 1996
Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesisG A Suarez, C Giannini, E P Bosch, et al.
JAMA|November 1, 2000
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator GroupS C Apfel, S Schwartz, B T Adornato, et al.
Journal of the Neurological Sciences|July 12, 2014
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trialsN Suanprasert, J L Berk, M D Benson, et al.
Pediatric Neurology|June 9, 2016
Pediatric Nerve Biopsy Diagnostic and Treatment Utility in Tertiary Care ReferralCristiane M Ida, Peter J Dyck, P James B Dyck, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 18, 2006
Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosisD H Kilfoyle, P J Dyck, Y Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2007
Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up dataP M Specenier, D Van den Weyngaert, C Van Laer, et al.
Diabetes Care|October 27, 2006
Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trialDan Ziegler, Alexander Ametov, Alexey Barinov, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 25, 2023
A reduction of skeletal muscle DHA content does not result in impaired whole body glucose tolerance or skeletal muscle basal insulin signaling in otherwise healthy miceJoshua M Budd, Barbora Hucik, Chenxuan Wang, et al.
Pageof 55

Showing results (471-480 of 549) with videos related to

Sort By:
Pageof 55
The American Journal of Physiology|September 2, 1998
Palmitate transport and fatty acid transporters in red and white musclesA Bonen, J J Luiken, S Liu, et al.
Journal of the Neurological Sciences|September 17, 2018
Kind and distribution of cutaneous sensation loss in hereditary transthyretin amyloidosis with polyneuropathyMarcus V Pinto, P James B Dyck, Linde E Gove, et al.
Neurology|February 1, 1996
Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesisG A Suarez, C Giannini, E P Bosch, et al.
JAMA|November 1, 2000
Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator GroupS C Apfel, S Schwartz, B T Adornato, et al.
Journal of the Neurological Sciences|July 12, 2014
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trialsN Suanprasert, J L Berk, M D Benson, et al.
Pediatric Neurology|June 9, 2016
Pediatric Nerve Biopsy Diagnostic and Treatment Utility in Tertiary Care ReferralCristiane M Ida, Peter J Dyck, P James B Dyck, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 18, 2006
Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosisD H Kilfoyle, P J Dyck, Y Wu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 8, 2007
Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up dataP M Specenier, D Van den Weyngaert, C Van Laer, et al.
Diabetes Care|October 27, 2006
Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trialDan Ziegler, Alexander Ametov, Alexey Barinov, et al.
American Journal of Physiology. Endocrinology and Metabolism|January 25, 2023
A reduction of skeletal muscle DHA content does not result in impaired whole body glucose tolerance or skeletal muscle basal insulin signaling in otherwise healthy miceJoshua M Budd, Barbora Hucik, Chenxuan Wang, et al.
Pageof 55